Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,000 | -8,625 | -5,866 | -2,808 | -9,948 |
| Depreciation Amortization | 107 | 85 | 54 | 25 | 81 |
| Accounts receivable | 15 | 48 | 12 | 24 | -48 |
| Accounts payable and accrued liabilities | 515 | -87 | 34 | 291 | -350 |
| Other Working Capital | 1,214 | -769 | -578 | -126 | -513 |
| Other Operating Activity | 629 | 810 | 443 | -86 | 2,176 |
| Operating Cash Flow | $-7,520 | $-8,537 | $-5,901 | $-2,679 | $-8,603 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,970 | N/A | N/A | N/A | N/A |
| PPE Investments | -275 | -209 | -155 | -62 | -67 |
| Investing Cash Flow | $-3,245 | $-209 | $-155 | $-62 | $-67 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,023 | 13,351 | 13,351 | 13,351 | 11,587 |
| Other Financing Activity | 0 | -1,327 | -1,327 | -1,327 | -52 |
| Financing Cash Flow | $12,023 | $12,023 | $12,023 | $12,024 | $11,535 |
| Beginning Cash Position | 6,901 | 6,901 | 6,901 | 6,901 | 4,036 |
| End Cash Position | 8,160 | 10,178 | 12,869 | 16,184 | 6,901 |
| Net Cash Flow | $1,259 | $3,277 | $5,968 | $9,283 | $2,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,520 | -8,537 | -5,901 | -2,679 | -8,603 |
| Capital Expenditure | -275 | -209 | -155 | -62 | -67 |
| Free Cash Flow | -7,795 | -8,746 | -6,056 | -2,741 | -8,670 |